Researcher.Life Logo

Neuro-Oncology : Impact Factor & More

eISSN: 1523-5866pISSN: 1522-8517

Key Metrics

CiteScore
18.8
Eigenfactor
0.01 - 0.05
H-Index
150
Impact Factor
15 - 20
Scite Index
0.89 5-Year SI
SJR
Q1Oncology
SNIP
3.17
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Neuro-Oncology

Neuro-Oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher OXFORD UNIV PRESS INC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1999
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Neuro-Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Neuro-Oncology

The emerging roles of cerebral pericytes in brain metastasis.
  • 19 May 2026
  • Neuro-oncology
TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.
  • 19 May 2026
  • Neuro-oncology
Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade Glioma.
  • 19 May 2026
  • Neuro-oncology
CIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant Gliomas.
  • 18 May 2026
  • Neuro-oncology
Modern Molecular Profiling Recontextualizes the NRG/RTOG 0539 Trial and Reveals Hidden High-Risk and Radiotherapy Resistant Meningiomas.
  • 15 May 2026
  • Neuro-oncology
Metabolic and Molecular Correlates of Medulloblastoma: Identification of Molecular Groups Using In Vivo 1H-MR Spectroscopy.
  • 14 May 2026
  • Neuro-oncology
The emerging roles of cerebral pericytes in brain metastasis.
  • 19 May 2026
  • Neuro-oncology
TRAM-01: A phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.
  • 19 May 2026
  • Neuro-oncology
Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade Glioma.
  • 19 May 2026
  • Neuro-oncology
CIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant Gliomas.
  • 18 May 2026
  • Neuro-oncology
Modern Molecular Profiling Recontextualizes the NRG/RTOG 0539 Trial and Reveals Hidden High-Risk and Radiotherapy Resistant Meningiomas.
  • 15 May 2026
  • Neuro-oncology
Metabolic and Molecular Correlates of Medulloblastoma: Identification of Molecular Groups Using In Vivo 1H-MR Spectroscopy.
  • 14 May 2026
  • Neuro-oncology

FAQs on Neuro-Oncology